ArticleJAMA network open2020

Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries.

Andrew Sumarsono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.